Cargando…

Tmem174, a regulator of phosphate transporter prevents hyperphosphatemia

Renal type II sodium-dependent inorganic phosphate (Pi) transporters NaPi2a and NaPi2c cooperate with other organs to strictly regulate the plasma Pi concentration. A high Pi load induces expression and secretion of the phosphaturic hormones parathyroid hormone (PTH) and fibroblast growth factor 23...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasaki, Sumire, Shiozaki, Yuji, Hanazaki, Ai, Koike, Megumi, Tanifuji, Kazuya, Uga, Minori, Kawahara, Kota, Kaneko, Ichiro, Kawamoto, Yasuharu, Wiriyasermkul, Pattama, Hasegawa, Tomoka, Amizuka, Norio, Miyamoto, Ken-ichi, Nagamori, Shushi, Kanai, Yoshikatsu, Segawa, Hiroko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012787/ https://www.ncbi.nlm.nih.gov/pubmed/35428804 http://dx.doi.org/10.1038/s41598-022-10409-3

Ejemplares similares

Simple But Efficacious Enrichment of Integral Membrane Proteins and Their Interactions for In-Depth Membrane Proteomics
por: Kongpracha, Pornparn, et al.
Publicado: (2022)

Role of sodium‐dependent Pi transporter/Npt2c on Pi homeostasis in klotho knockout mice different properties between juvenile and adult stages
por: Hanazaki, Ai, et al.
Publicado: (2020)

Membrane transport proteins in melanosomes: Regulation of ions for pigmentation
por: Wiriyasermkul, Pattama, et al.
Publicado: (2020)

Specific transport of 3‐fluoro‐l‐α‐methyl‐tyrosine by LAT1 explains its specificity to malignant tumors in imaging
por: Wei, Ling, et al.
Publicado: (2016)

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2
por: Wongthai, Printip, et al.
Publicado: (2015)

Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With α-Alkyl Moieties
por: Khunweeraphong, Narakorn, et al.
Publicado: (2012)

Ca(2+)-mediated higher-order assembly of heterodimers in amino acid transport system b(0,+) biogenesis and cystinuria
por: Lee, Yongchan, et al.
Publicado: (2022)

Consensus mutagenesis approach improves the thermal stability of system x(c) (−) transporter, xCT, and enables cryo‐EM analyses
por: Oda, Kazumasa, et al.
Publicado: (2020)

Parkinson’s disease-associated ATP13A2/PARK9 functions as a lysosomal H(+),K(+)-ATPase
por: Fujii, Takuto, et al.
Publicado: (2023)

Individual dosimetry system for targeted alpha therapy based on PHITS coupled with microdosimetric kinetic model
por: Sato, Tatsuhiko, et al.
Publicado: (2021)

Ratiometric fluorescence imaging of cell surface pH by poly(ethylene glycol)-phospholipid conjugated with fluorescein isothiocyanate
por: Ohgaki, Ryuichi, et al.
Publicado: (2017)

Analysis of promoters and CREB/AP-1 binding sites of the human TMEM174 gene
por: HU, FEN, et al.
Publicado: (2013)

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
por: Shi, Zitong, et al.
Publicado: (2023)

Analysis of TMEM174 gene expression in various renal cancer types by RNA in situ hybridization
por: ZHANG, XIUJUN, et al.
Publicado: (2014)

Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
por: Quan, Lili, et al.
Publicado: (2020)

Hyperphosphatemia and Cardiovascular Disease
por: Zhou, Chao, et al.
Publicado: (2021)

Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
por: Isoda, Atsushi, et al.
Publicado: (2014)

Effect of Intradialytic Exercise on Hyperphosphatemia and Malnutrition
por: Salhab, Nada, et al.
Publicado: (2019)

Control of hyperphosphatemia and maintenance of calcemia in CKD
por: Carvalho, Aluizio Barbosa, et al.
Publicado: (2021)

Phosphate intake, hyperphosphatemia, and kidney function
por: Rubio-Aliaga, Isabel, et al.
Publicado: (2022)

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer
por: Kaira, Kyoichi, et al.
Publicado: (2013)

Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma
por: Ohshima, Yasuhiro, et al.
Publicado: (2016)

Hall 174
por: Jacob, U
Publicado: (1977)

NRFL-1, the C. elegans NHERF Orthologue, Interacts with Amino Acid Transporter 6 (AAT-6) for Age-Dependent Maintenance of AAT-6 on the Membrane
por: Hagiwara, Kohei, et al.
Publicado: (2012)

Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
por: Lenglet, Aurélie, et al.
Publicado: (2013)

Hyperphosphatemia: The hidden killer in chronic kidney disease
por: Askar, Akram M.
Publicado: (2015)

Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia
por: Koratala, Abhilash
Publicado: (2017)

Hyperphosphatemia is associated with high mortality in severe burns
por: Kuo, George, et al.
Publicado: (2018)

Uremic Tumoral Calcinosis Resolved by Improvements in Hyperphosphatemia
por: Watanabe, Hirofumi, et al.
Publicado: (2017)

Hyperphosphatemia Management in Patients with Chronic Kidney Disease
por: Shaman, Ahmed M., et al.
Publicado: (2016)

Non-occlusive Mesenteric Ischemia with Significant Hyperphosphatemia
por: Yamada, Aki, et al.
Publicado: (2022)

Negative regulation of amino acid signaling by MAPK-regulated 4F2hc/Girdin complex
por: Weng, Liang, et al.
Publicado: (2018)

A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway
por: Wang, Joseph, et al.
Publicado: (2017)

Memorandum: PS 174
por: Davies, J D
Publicado: (1985)

From 174 to 107
por: CERN Bulletin
Publicado: (2012)

T174. ANTIPSYCHOTICS AND THE MICROBIOME
por: Chen, Anderson, et al.
Publicado: (2020)

Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis
por: Vasantha, J., et al.
Publicado: (2011)

NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD
por: Larsson, Tobias E., et al.
Publicado: (2017)

Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
por: Palafox-Serdán, Frida, et al.
Publicado: (2020)

Npt2a as a target for treating hyperphosphatemia
por: Thomas, Linto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_648kg4g9v07r4pmolibj1drhq6